Another RCT found a decrease in homocysteine with 1000 g hydroxo-B12 monthly for 3 months by 2 mol/l, whilst the control group had a 2 mol/l increase, although the difference was not statistically significant
Typical workflows include fibroblast or keratinocyte culture assays for gene expression and proliferation readouts, accelerated stability studies in candidate base formulations, and side-by-side comparison against alternative peptide chemistries
Domain I exhibits the structurally conserved thioredoxin-like fold motif (Figure 3A&C) [44, 68, 75]
Neurological symptoms can be particularly concerning and may occur even in the absence of anaemia
Sample size calculations were based on phase 2 trial data, which predicted a treatment difference of 1.0 in the Female Sexual Function Index-desire domain (FSFI-D) score and about 20.43 points in the Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO) item 13, with a total of 450 evaluable patients providing sufficient statistical power to detect significant differences
